Published in J Clin Invest on February 01, 1994
Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest (2000) 3.03
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev (2010) 2.57
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev (1999) 2.37
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med (2006) 2.30
Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci U S A (2000) 2.23
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12
Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) (2009) 2.06
Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol (2006) 2.04
Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J Clin Invest (1997) 1.68
Alternative polyadenylation of cyclooxygenase-2. Nucleic Acids Res (2005) 1.61
Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest (1997) 1.54
P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J (2002) 1.48
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res (2010) 1.44
Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A (1996) 1.40
alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol Biol Cell (2000) 1.39
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia (2001) 1.32
Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer (2000) 1.31
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer (1999) 1.25
Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest (1997) 1.25
Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci U S A (2000) 1.22
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest (2006) 1.18
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut (2000) 1.15
Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Mol Cancer Res (2008) 1.04
Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol (2004) 0.98
Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia (2001) 0.98
Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription. J Biol Chem (2008) 0.97
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila) (2009) 0.97
Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci (2001) 0.96
Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma. World J Gastroenterol (2003) 0.95
Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia (1999) 0.94
Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci (2003) 0.93
Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. Am J Physiol Gastrointest Liver Physiol (2009) 0.91
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br J Cancer (2003) 0.90
Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth. Neoplasia (1999) 0.90
Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. J Clin Invest (1997) 0.88
Macrophage and T-lymphocyte infiltrates in human peritoneal adhesions indicate a chronic inflammatory disease. World J Surg (2008) 0.87
Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem J (1995) 0.87
Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc (2014) 0.85
Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells. Infect Immun (2007) 0.85
Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines. J Gastroenterol (2008) 0.85
Cyclooxygenase-2 and its regulation in inflammation. Mediators Inflamm (1996) 0.84
Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana. World J Gastroenterol (2006) 0.83
Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study. Gut (1996) 0.83
Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. Neoplasia (2002) 0.82
The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation. Mediators Inflamm (1998) 0.82
The role of peroxisome proliferator-activated receptors in colorectal cancer. PPAR Res (2012) 0.81
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers. Cancer Prev Res (Phila) (2013) 0.80
Sulindac metabolites inhibit epidermal growth factor receptor activation and expression. J Carcinog (2005) 0.80
Restoration of on-time embryo implantation corrects the timing of parturition in cytosolic phospholipase A2 group IVA deficient mice. Biol Reprod (2009) 0.79
Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells. Neoplasia (2005) 0.78
Haemorrhoids are related to changes of cell function in mucosa and submucosa. Int J Colorectal Dis (2009) 0.78
The role of apoptosis in intestinal disease. J Gastroenterol (1997) 0.77
The role of prostaglandins in gastric mucosal protection. Trans Am Clin Climatol Assoc (1996) 0.76
Prostacyclin regulates bone growth via the Epac/Rap1 pathway. Endocrinology (2014) 0.76
Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile. Redox Biol (2014) 0.76
Staurosporine synergistically potentiates the deoxycholate-mediated induction of COX-2 expression. Physiol Rep (2014) 0.75
A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk. Clin Infect Dis (2017) 0.75
Perturbed meibomian gland and tarsal plate morphogenesis by excess TGFα in eyelid stroma. Dev Biol (2015) 0.75
Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor. Clin Exp Metastasis (2003) 0.75
Low endogenous prostaglandin E2 predisposes to relapsing inflammation in experimental rat enterocolitis. Dig Dis Sci (2000) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem (1991) 5.62
Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem (1991) 5.48
Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A (1992) 5.21
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A (1991) 5.07
Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem (1993) 4.05
Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci U S A (1986) 3.71
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A (1992) 3.65
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (1983) 3.56
The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol (1991) 3.08
Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol Cell Biol (1987) 2.97
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res (1992) 2.47
A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem (1990) 2.39
Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem (1992) 1.97
Sulindac for polyposis of the colon. Am J Surg (1989) 1.95
Serum-inducible genes. Adv Cancer Res (1989) 1.53
Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem (1992) 1.33
Regional localization of prostacyclin and thromboxane synthesis in dog stomach and intestinal tract. J Pharmacol Exp Ther (1979) 1.26
Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions. J Biol Chem (1993) 1.19
Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ (1992) 1.11
The hydrophobic amino-terminal sequence of bovine 17 alpha-hydroxylase is required for the expression of a functional hemoprotein in COS 1 cells. J Biol Chem (1991) 1.05
Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine. Biochem J (1985) 1.01
Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J Biol Chem (1991) 1.01
Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells. J Biol Chem (1993) 1.00
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96
Genes induced during the G0/G1 transition in mouse fibroblasts. Semin Cancer Biol (1990) 0.94
Effect of glucocorticoids on oncogene transformed NIH3T3 cells. Oncogene (1990) 0.91
Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett (1984) 0.85
Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. Prostaglandins (1992) 0.82
A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta Earthquake. J Pers Soc Psychol (1991) 6.75
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A (1990) 5.31
Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door? N Engl J Med (1995) 4.77
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med (1991) 3.65
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J Biol Chem (1997) 3.42
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Response styles and the duration of episodes of depressed mood. J Abnorm Psychol (1993) 2.88
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem (1990) 2.84
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. J Consult Clin Psychol (1999) 2.60
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A (1992) 2.51
Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol (1999) 2.40
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA (1999) 2.34
Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure (1999) 2.18
Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology (1999) 2.16
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A (2001) 2.12
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res (1997) 2.02
Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology (2008) 1.96
Measurement of lipid peroxidation. Free Radic Res (1998) 1.91
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest (1992) 1.77
Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem (1994) 1.76
HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis (1986) 1.66
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy (2001) 1.62
Sensitivity of three median-to-ulnar comparative tests in diagnosis of mild carpal tunnel syndrome. Muscle Nerve (1993) 1.59
Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A (1999) 1.57
Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci U S A (1985) 1.55
The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol (1996) 1.53
Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. Arthritis Rheum (1984) 1.52
In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. Neurology (2014) 1.52
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins (1989) 1.49
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J Biol Chem (1999) 1.47
Are anaesthetists prone to suicide? A review of rates and risk factors. Anaesth Intensive Care (2003) 1.46
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Prevention of skin cancer in xeroderma pigmentosum: the physician as advocate. J Am Acad Dermatol (1993) 1.44
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
The gene for an inherited form of deafness maps to chromosome 5q31. Proc Natl Acad Sci U S A (1992) 1.42
The effects of alcohol on the marital interactions of aggressive and nonaggressive husbands and their wives. J Abnorm Psychol (1998) 1.41
Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. J Biol Chem (1985) 1.40
Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Arch Dermatol (1991) 1.40
Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem (1994) 1.40
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1991) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Placental isoprostane is significantly increased in preeclampsia. FASEB J (2000) 1.38
Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J Infect (2005) 1.38
A physiologic concept of exercise-induced pulmonary hemorrhage in horses. J Am Vet Med Assoc (1992) 1.38
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Colonic sunflower seed bezoar. Pediatrics (1997) 1.34
Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun (2004) 1.33
Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol (1994) 1.33
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol (2013) 1.33
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem (1998) 1.33
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins (1992) 1.30
Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem (1982) 1.30
Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol (1992) 1.28
Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J Biol Chem (1999) 1.27
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest (1992) 1.26
Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann Neurol (1998) 1.23
Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim Biophys Acta (1994) 1.23
HLA antigen associations with extra-articular rheumatoid arthritis. Tissue Antigens (1984) 1.22
Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem (1994) 1.22
STAT: a saccharide topology analysis tool used in combination with tandem mass spectrometry. Anal Chem (2000) 1.22
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol (2002) 1.20
Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. J Immunol (1979) 1.20
Clinical implications of prostaglandin and thromboxane A2 formation (2). N Engl J Med (1988) 1.19
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol (1993) 1.19
Increased CSF F2-isoprostane concentration in probable AD. Neurology (1999) 1.19
Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study. Pediatrics (1979) 1.18
Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. Arch Biochem Biophys (1998) 1.16
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol (1992) 1.15
Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med (1999) 1.14
Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology (2006) 1.13
Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res (1990) 1.13
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. N Engl J Med (1981) 1.12
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am J Pathol (1999) 1.12
New HLA DNA polymorphisms associated with autoimmune diseases. Nature (1986) 1.11
Isoniazid and action tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry (1985) 1.11
HLA and rheumatoid arthritis: an analysis of multicase families. Dis Markers (1986) 1.10
Increased lipid peroxidation in patients with rhabdomyolysis. Lancet (1999) 1.10
Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Adv Shock Res (1982) 1.10
Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med (1985) 1.09
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry (2000) 1.09
A nomenclature system for the isoprostanes. Prostaglandins (1997) 1.08
First trimester fetal nuchal translucency: problems with screening the general population. 2. Br J Obstet Gynaecol (1995) 1.08
Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv (1997) 1.07
Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology (2011) 1.06
Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest (1994) 1.06
Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J Immunol (1998) 1.05
Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun (1993) 1.05